Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Other Working Capital Changes (2010 - 2026)

Palatin Technologies' (PTN) quarterly Other Working Capital Changes came in at -$1.1 million in Q1 2026, down 1049.68% on a YoY basis from $115641.1 in Q1 2025, and down 194.31% quarter-over-quarter from $1.2 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Other Working Capital Changes for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Other Working Capital Changes fell 1049.68% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2026 stood at -$224276.0 (up 23.82% YoY), and the FY2025 full-year result was -$380543.0, up 68.78% from the prior year.
  • Other Working Capital Changes retreated to -$1.1 million in Q1 2026 per PTN's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.5 million in Q2 2022 and bottomed at -$1.6 million in Q4 2023.
  • Historically, Other Working Capital Changes has averaged -$17008.1 across 5 years, with a median of -$94223.0 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes slumped 7098.71% in 2023, then surged 1335.92% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$22375.0 in 2022, then plunged by 7098.71% to -$1.6 million in 2023, then surged by 94.15% to -$94223.0 in 2024, then soared by 1335.92% to $1.2 million in 2025, then sank by 194.31% to -$1.1 million in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.1 million, $1.2 million, and -$192143.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.10 Mn
Mar 31, 2026 -1.10 Mn
Dec 31, 2025 1.16 Mn
Dec 31, 2025 1.16 Mn
Sep 30, 2025 -192,143.00
Sep 30, 2025 -192,143.00
Jun 30, 2025 -98,439.00
Jun 30, 2025 -98,439.00
Mar 31, 2025 -95,524.00
Mar 31, 2025 -95,524.00
Dec 31, 2024 -94,223.00
Dec 31, 2024 -94,223.00
Sep 30, 2024 -92,357.00
Sep 30, 2024 -92,357.00
Jun 30, 2024 -12,282.00
Jun 30, 2024 -12,282.00
Mar 31, 2024 -159,400.00
Mar 31, 2024 -159,400.00
Dec 31, 2023 -1.61 Mn
Dec 31, 2023 -1.61 Mn